247 related articles for article (PubMed ID: 34218486)
21. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
[TBL] [Abstract][Full Text] [Related]
22. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology.
Llorens F; Thüne K; Andrés-Benito P; Tahir W; Ansoleaga B; Hernández-Ortega K; Martí E; Zerr I; Ferrer I
J Mol Neurosci; 2017 Oct; 63(2):206-215. PubMed ID: 28871468
[TBL] [Abstract][Full Text] [Related]
24. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
25. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
[TBL] [Abstract][Full Text] [Related]
26. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
27. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.
Whitwell JL; Josephs KA; Murray ME; Kantarci K; Przybelski SA; Weigand SD; Vemuri P; Senjem ML; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW; Jack CR
Neurology; 2008 Sep; 71(10):743-9. PubMed ID: 18765650
[TBL] [Abstract][Full Text] [Related]
28. Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease.
Nakano H; Kobayashi K; Sugimori K; Shimazaki M; Miyazu K; Hayashi M; Furuta H
Dement Geriatr Cogn Disord; 2004; 17(3):122-31. PubMed ID: 14739532
[TBL] [Abstract][Full Text] [Related]
29. Dysregulated Protein Phosphorylation in a Mouse Model of FTLD-Tau.
Ferrer I; Andrés-Benito P; Ausín K; Cartas-Cejudo P; Lachén-Montes M; Del Rio JA; Fernández-Irigoyen J; Santamaría E
J Neuropathol Exp Neurol; 2022 Aug; 81(9):696-706. PubMed ID: 35848963
[TBL] [Abstract][Full Text] [Related]
30. Senile dementia of the neurofibrillary tangle type: a comparison with Alzheimer's disease.
Yamada M; Itoh Y; Sodeyama N; Suematsu N; Otomo E; Matsushita M; Mizusawa H
Dement Geriatr Cogn Disord; 2001; 12(2):117-26. PubMed ID: 11173884
[TBL] [Abstract][Full Text] [Related]
31. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.
Luna-Muñoz J; García-Sierra F; Falcón V; Menéndez I; Chávez-Macías L; Mena R
J Alzheimers Dis; 2005 Sep; 8(1):29-41. PubMed ID: 16155347
[TBL] [Abstract][Full Text] [Related]
32. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
33. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
34. Spreading of Tau Pathology in Sporadic Alzheimer's Disease Along Cortico-cortical Top-Down Connections.
Braak H; Del Tredici K
Cereb Cortex; 2018 Sep; 28(9):3372-3384. PubMed ID: 29982389
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components.
Yen SH; Liu WK; Hall FL; Yan SD; Stern D; Dickson DW
Neurobiol Aging; 1995; 16(3):381-7. PubMed ID: 7566347
[TBL] [Abstract][Full Text] [Related]
36. Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments.
Kimura T; Ono T; Takamatsu J; Yamamoto H; Ikegami K; Kondo A; Hasegawa M; Ihara Y; Miyamoto E; Miyakawa T
Dementia; 1996; 7(4):177-81. PubMed ID: 8835879
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
Muntané G; Dalfó E; Martinez A; Ferrer I
Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
[TBL] [Abstract][Full Text] [Related]
38. Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease.
Bussière T; Gold G; Kövari E; Giannakopoulos P; Bouras C; Perl DP; Morrison JH; Hof PR
Neuroscience; 2003; 117(3):577-92. PubMed ID: 12617964
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
[TBL] [Abstract][Full Text] [Related]
40. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA
Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
